SightfileU.S. market data from official filings

Companies › IMNM

IMMUNOME INC (IMNM)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001472012 · EDGAR filings · Updated 2026-07-27

IMMUNOME INC (IMNM) has reported institutional ownership of 103.1%, with 199 institutional managers holding positions valued at $2.54B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
103.1%
Institutional managers
199
Reported 13F value
$2.54B
Insider activity
20 trans.
−$7.62M net selling
Data flags
1 active
from SEC filings

Filings this week (6)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, IMMUNOME INC has 199 institutional holders and institutional ownership of 103.1%.

Insider activity

Insiders reported 20 transactions (8 buys, 4 sells) across 6 reporting insiders, with a net reported value of −$7.62M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2020-11-16 (recurring since 2020-11-16) — source filing. The authoritative details are those stated in the filing itself.

Related companies

BEAM THERAPEUTICS INC (BEAM) · ARCUS BIOSCIENCES INC COM (RCUS) · ORUKA THERAPEUTICS INC (ORKA) · TYRA BIOSCIENCES INC (TYRA) · PRIVIA HEALTH GROUP INC (PRVA) · NATIONAL VISION HLDGS INC COM (EYE)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.